Detalhe da pesquisa
1.
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRIâ¯+â¯Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer.
Dig Liver Dis
; 53(4): 420-426, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33358124
2.
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
Clin Genitourin Cancer
; 19(6): 554-562, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34602349
3.
Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer.
EJNMMI Res
; 4(1): 12, 2014 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24602385